37 results
Page 2 of 2
6-K
EX-99.1
2kcllsawegu 5eff6mwo
4 May 20
Current report (foreign)
8:32am
6-K
EX-99.2
9ix xbg8088e
30 Mar 20
AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook
9:08am
CORRESP
d2z9d169pq6xoi1
17 Jan 20
Correspondence with SEC
12:00am
CORRESP
phno1lbe
20 Dec 19
Correspondence with SEC
12:00am
20-F/A
EX-4.14
4byyko4lp9 dmrxij
19 Apr 19
Annual report (foreign) (amended)
5:07pm
6-K
EX-99.2
071cqiap 0t0
21 Mar 19
Current report (foreign)
7:44am
6-K
EX-99.2
4aypknna 3w9bkvul
13 Nov 18
Current report (foreign)
6:05am
424B5
eot5dqp7dajz w0rz
20 Jul 18
Prospectus supplement for primary offering
6:03am
424B5
r9iwxii0ahc vlfr49k
19 Jul 18
Prospectus supplement for primary offering
4:17pm
424B5
sxt9n86
17 Jul 18
Prospectus supplement for primary offering
4:08pm
6-K
u2fejk ufm
7 Jun 18
Invitation to the Ordinary Shareholders' Meeting
4:06pm
CORRESP
pwj1g34jhf3z
25 May 18
Correspondence with SEC
12:00am
20-F
ki0ppe5iox
17 Mar 17
Annual report (foreign)
12:00am